Top image

Cusack GroupCollaborations

Stephen Cusack

  • Rig-I
    D. Kolakofsky, University of Geneva, Switzerland
    D. Gerlier, INSERM, Lyon, France
  • Leucyl-tRNA synthetase
    S. Martinis, University of Illinois, Urbana, USA
    Ita Gruic Sovulj, University of Zagreb, Croatia
  • Influenza polymerase
    R. Ruigrok, University of Grenoble, France
    J. Ortin, CSIC, Madrid, Spain
    Nadia Naffakh, Pasteur Institute Paris, France
    J.Briggs, EMBL Heidelberg, Germany
  • Influenza anti-viral drug design
    O. Szolar, Savira Pharmaceuticals, Vienna, Austria
    R. Weikert, Roche, Basle
    J. Gao, Roche, Basle
  • Antibiotics targeting leucyl-tRNA synthetase
    D. Alley, Anacor pharamaceuticals, Palo Alto, USA
  • Dosage Compensation Complex
    A. Akhtar, MPI, Freiburg, Germany
  • CBC, ARS2
    E. Bertrand, CNRS Montpellier, France
  • La Crosse Virus polymerase
    F. Weber, University of Marburg, Germany